SEC Form 5 · accession 0001232524-16-000182
Jazz Pharmaceuticals plc · JAZZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Suzanne Sawochka Hooper
Officer — EVP & General Counsel
Period of report
Dec 31, 2015
Accepted (ET)
Feb 11, 2016 · 5:13 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Dec 7, 2015 | G | 260 | $0.00 | D | 35,647 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 52 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 30, 2015.